Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
11/26/1992 | WO1992020822A1 Backbone modified oligonucleotide analogues |
11/26/1992 | WO1992020811A2 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
11/26/1992 | WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY |
11/26/1992 | WO1992020707A1 Bombesin analogs |
11/26/1992 | WO1992020681A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
11/26/1992 | WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
11/26/1992 | WO1992020643A1 Novel bi-aromatic compounds derived from a salicilic pattern, method of preparation and use in human and veterinary medecine and in cosmetics |
11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
11/26/1992 | WO1992020360A1 Method of using substance p to treat allergy |
11/26/1992 | WO1992020344A1 Antiviral combinations containing nucleoside analogs |
11/26/1992 | WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
11/26/1992 | CA2471093A1 Determination of motifs of peptides on mhc molecules |
11/26/1992 | CA2109843A1 Method of using substance p to treat allergy |
11/26/1992 | CA2109702A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
11/26/1992 | CA2108880A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
11/26/1992 | CA2103378A1 Backbone modified oligonucleotide analogues |
11/26/1992 | CA2103159A1 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
11/26/1992 | CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily |
11/25/1992 | WO1992021313A2 Novel immunosuppressive compounds |
11/25/1992 | EP0515301A2 Improvements in benzodiazepine treatment by cholinesterterase inhibitors |
11/25/1992 | EP0515257A1 1-phenyl-1,4-dihydro-3-hydroxy-4-oxo-pyridazine derivatives, their preparation and their therapeutic use |
11/25/1992 | EP0515240A1 N-alkylidene piperidine compounds and their enatiomers, process for their preparation and pharmaceutical compositions containing them |
11/25/1992 | EP0515158A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
11/25/1992 | EP0515140A1 Amide esters of rapamycin |
11/25/1992 | EP0515071A2 O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
11/25/1992 | EP0514458A1 Assays and treatments for autoimmune diseases |
11/25/1992 | CA2102178A1 Novel immunosuppressive compounds |
11/24/1992 | US5166205 Antiallergens or antihistamines with five membered azole ring |
11/24/1992 | US5166196 Method for removing immunocomplexes from blood |
11/24/1992 | US5166170 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders |
11/24/1992 | US5166161 Antiallergens or antiinflammatory agents |
11/24/1992 | US5166152 Immunostimulants, bactericides, viricides, antitumor agents |
11/24/1992 | US5166141 Antigen specific immunune response by contacting lymphocytes |
11/24/1992 | CA1310647C Heteroaryl 3-oxo-propanenitrile derivatives and process for their preparation |
11/24/1992 | CA1310642C 2-amino-5-hydroxy-4-pyrimidones |
11/22/1992 | CA2103464A1 Backbone modified oligonucleotide analogs |
11/21/1992 | CA2068567A1 Amide esters of rapamycin |
11/19/1992 | EP0514367A2 Protein C-containing drug |
11/19/1992 | EP0514276A1 Thiopyranopyrrole derivatives and their preparation |
11/19/1992 | EP0514275A1 Thiopyranopyrrole derivatives, their preparation and pharmaceutical compositions containing them |
11/19/1992 | EP0514269A1 Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics |
11/19/1992 | EP0514264A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics |
11/19/1992 | EP0514144A2 Rapamycin metabolites |
11/19/1992 | EP0513917A1 Antiviral combinations containing nucleoside analogs |
11/19/1992 | EP0513861A1 Vaccine adjuvant comprising a tetra-polyol |
11/19/1992 | EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
11/19/1992 | EP0513671A1 Commiphora mukul extracts and therapeutical applications thereof |
11/19/1992 | EP0513434A1 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/acetylsalicylic acid (DISALAZINE) |
11/19/1992 | EP0513387A1 Active oxygen inhibitor |
11/19/1992 | EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications |
11/19/1992 | EP0513150A1 New method for treating immunodeficiency or neutropenia |
11/19/1992 | EP0513104A1 USE OF AN -g(a)-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED. |
11/19/1992 | EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES. |
11/18/1992 | WO1992020686A1 Novel derivatives of thiopyranopyrrole and preparation thereof |
11/18/1992 | WO1992020685A1 Novel derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them |
11/18/1992 | CN1066192A Pulmonary administration of granulocyte colony stimulating factor |
11/18/1992 | CA2109296A1 New thiopyranopyrrole derivatives; process for preparing the same and pharmaceutical compositions containing them |
11/18/1992 | CA2109295A1 New thiopyranopyrrole derivatives and process for preparing them |
11/17/1992 | US5164194 Treatment of irritated eye and nose mucous membranes resulting from a cold or allergy |
11/17/1992 | US5164189 Single layer transdermal drug administration system |
11/17/1992 | CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines |
11/17/1992 | CA1310443C Glutamic acid derivatives, their salts, process of preparation, applications as medications, and compositions containing them |
11/17/1992 | CA1310266C Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions |
11/16/1992 | CA2068696A1 Imine-derived aromatic compounds, process for their preparation and their use in human and veterinary medecine, and in cosmetics |
11/16/1992 | CA2052696A1 5-//4-/(4',6'-dimethyl 1-2-pyrimidinyl) sulfamoyl / phenyl/ azo/acetylsalicyclic acid |
11/14/1992 | CA2068561A1 O-aryl, o-alkyl, o-alkenyl and o-alkynylmacrolides having immunosuppressive activity |
11/12/1992 | WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
11/12/1992 | WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions |
11/12/1992 | WO1992019593A1 Novel immunosuppressive compounds |
11/12/1992 | WO1992019278A1 Use of macrolide compounds for eye diseases |
11/12/1992 | WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes |
11/12/1992 | WO1992019105A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
11/12/1992 | WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
11/12/1992 | CA2109120A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
11/12/1992 | CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes |
11/11/1992 | EP0512902A1 Dialkyleneperidino compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512901A1 Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512899A1 Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512754A1 Reduction products of rapamycin as immunosuppressants antiinflammatory or antifungal agents |
11/11/1992 | EP0512733A2 Modified complement system regulator |
11/11/1992 | EP0512528A2 Pharmaceutical compositions comprising an anticytokine |
11/11/1992 | EP0298134B1 Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same |
11/11/1992 | EP0202300B1 Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity |
11/11/1992 | CN1066062A Pharmaceutical compound |
11/11/1992 | CN1066060A Pharmaceutical compound |
11/10/1992 | US5162569 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
11/10/1992 | US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
11/10/1992 | US5162328 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
11/10/1992 | US5162316 Pyrimido[4,5-d]pyrimidine derivatives for use as bronchodilators |
11/10/1992 | CA1310020C 1-aminophenyl-2-dimethylaminopropanone derivatives, method of preparation and use in therapy |
11/10/1992 | CA1310010C Benzimidazole derivatives, their preparation and their application in therapeutics |
11/04/1992 | EP0511879A1 Pyrazine derivatives |
11/04/1992 | EP0511271A1 Thiazole derivatives |
11/04/1992 | EP0511270A1 New thiazole derivatives |
11/04/1992 | CA2067905A1 Benzopyranic compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
11/04/1992 | CA2067834A1 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
11/03/1992 | WO1992019594A1 Pyrrolidinones |
11/03/1992 | CA2102106A1 Pyrrolidinones |
11/03/1992 | CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them |